RNA-targeting Molecule May Open New Avenue For Treating Parkinson’s, Study Suggests

RNA-targeting Molecule May Open New Avenue For Treating Parkinson’s, Study Suggests
A new small molecule called synucleozid can prevent cells from producing the Parkinson’s-associated protein alpha-synuclein by inhibiting its translation from RNA, a study shows. The study, “Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA,” was published in the journal Proceedings of the National Academy of Sciences. It supports the strategy of ... read more
Source: Parkinson’s News TodayPublished on 2020-01-27By Marisa Wexler